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Objectives: The aim of this prospective longitudinal multicenter study was to dissect colonization
from infection in patients with Staphylococcus aureus cultured from the airways by determining a
variety of host- and pathogen-speciﬁc parameters.
Methods: Inclusion criteria: >6 years, persistent S. aureus cultures from airway specimens. Specimens
were processed at the study laboratory in Muenster. Clincal data, lung function and antibiotic therapy
were recorded. Sera were taken once a year and during exacerbations. Microbiological processing
included determination of the density of microorganisms. Isolates were molecular typed by spa-typing.
Prevalence of important virulence genes was assessed by single and multiplex PCR.
Results: Data were collected for 195 patients from 17 centers in Germany and Austria: 75 female
(38.5%); mean age 15.7 years (range 5 to 41 y), 49% DF508 homozygous. Data from 1359 visits were
evaluated (mean visits/patient 7). There was a signiﬁcant correlation of bacterial density (> or <1×105
CFU/ml) and lung function FEV1 (p = 0.017). S. aureus nasal carriers had better lung functions
compared to non-carriers, but had a steeper decline of FEV1%. IL-6 values were signiﬁcantly higher
in patients with high bacterial loads in sputum cultures. Most patients carried their individual clones.
Some virulence factors seem to be associated with CF isolates.
Conclusion: There was a signiﬁcant correlation of lung function, IL-6 values and bacterial density
in sputa. Future studies should determine, if patients will beneﬁt from antibiotic treatment, which is
guided by determining the bacterial load in airway specimens.
